Benitec Biopharma Inc.
12.45USD
-0.2750 (-2.16%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.27▲ | $-0.29 | 2 | 2 |
| Next quarter | $-0.28▲ | $-0.31 | 3 | 0 |
| Current year | $-0.99▲ | $-1 | 4 | 0 |
| Next year | $-1.12▲ | $-1.15 | 3 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-03-31 | $-0.28 | $-0.24 | +0.04 (+12.7%) |
| 2025-12-31 | $-0.23 | $-0.26 | -0.03 (-15.0%) |
| 2025-09-30 | $-0.36 | $-0.22 | +0.14 (+38.2%) |
| 2025-06-30 | $-0.31 | $-0.42 | -0.11 (-34.2%) |
22 ratings from 11 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wedbush | Initiated | Outperform | $16 | Jul 28, 2026 |
| Evercore ISI Group | Initiated | Outperform | $25 | May 12, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $32 | Mar 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $35 $32 | Nov 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $28 $35 | Nov 4, 2025 |
| Citizens | Maintained | Market Outperform | $20 $22 | Nov 4, 2025 |
| JMP Securities | Reiterated | Market Outperform | $20 | Sep 24, 2025 |
| Oppenheimer | Maintained | Outperform | $35 $29 | Sep 16, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $28 | May 19, 2025 |
| JMP Securities | Reiterated | Market Outperform | $20 | May 15, 2025 |
| JMP Securities | Maintained | Market Outperform | $18 $20 | Apr 10, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $28 | Mar 24, 2025 |
| Citizens Capital Markets | Reiterated | Market Outperform | $18 | Mar 18, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $28 | Feb 21, 2025 |
| Baird | Initiated | Outperform | $30 | Dec 13, 2024 |
| Guggenheim | Reiterated | Buy | $17 | Dec 3, 2024 |
| Leerink Partners | Initiated | Outperform | $13 | Jul 22, 2024 |
| Piper Sandler | Initiated | Overweight | $30 | Jun 13, 2024 |
| JMP Securities | Maintained | Market Outperform | $10 $16 | Apr 22, 2024 |
| JMP Securities | Maintained | Market Outperform | $8 $10 | Feb 15, 2024 |
| JMP Securities | Maintained | Market Outperform | $6 $8 | Jan 24, 2024 |
| JMP Securities | Maintained | Market Outperform | $4 $6 | Sep 26, 2023 |
12 filings from 2 insiders · 0 buy / 0 sell over 6m
Officers and directors of BNTC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BUCHI J. KEVINDirector | Gift | 51.8k | — | — | Jun 29, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 144.2k | $12.85 | $1.90M | Dec 29, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 46.1k | $11.24 | $539k | Dec 22, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCDirector and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 1.48M | $13.50 | $20.00M | Nov 7, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 16.5k | $12.63 | $212k | Mar 31, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 900.0k | $13.00 | $11.70M | Mar 26, 2025 |
| BUCHI J. KEVINDirector | Gift | 103.6k | — | — | Mar 12, 2025 |
| BUCHI J. KEVINDirector | Exercise | 51.8k | $3.86 | $200k | Feb 27, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLCDirector and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 47.5k | $10.98 | $527k | Dec 24, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLCDirector and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 42.0k | $9.60 | $403k | Dec 3, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLCDirector and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 41.4k | $9.73 | $417k | Nov 20, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLCBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 7.14M | — | $21.14M | Sep 26, 2024 |
Analyst Ratings
6 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 6 | 0 | 0 | 0 | Buy1.86 |
| 1 mo ago | 1 | 6 | 0 | 0 | 0 | Buy1.86 |
| 2 mo ago | 1 | 6 | 0 | 0 | 0 | Buy1.86 |
| 3 mo ago | 1 | 5 | 0 | 0 | 0 | Buy1.83 |